QuantaBio   Report issue

For profit Phase 3 Phase 4
Founded: Rueil-Malmaison France (1986)
Status: No NME R&D (1986)

Organization Overview

First Clinical Trial
2007
NCT00882531
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Quanta Medical

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colitis (Phase 3)

Onychomycosis (Phase 4)

Rosacea (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 7